• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Correlation of caffeine elimination and Child's classification in liver cirrhosis.

作者信息

Holstege A, Staiger M, Haag K, Gerok W

机构信息

Abteilung Innere Medizin, Albert-Ludwigs-Universität, Freiburg.

出版信息

Klin Wochenschr. 1989 Jan 4;67(1):6-15. doi: 10.1007/BF01736528.

DOI:10.1007/BF01736528
PMID:2921843
Abstract

Apparent pharmacokinetic parameters of caffeine elimination from the circulation were determined in 27 patients with histologically confirmed liver cirrhosis, 8 patients with miscellaneous liver disease, and 8 patients with other than liver disease. The usefullness of this quantitative test to assess the severity of liver cirrhosis was compared to the Child-Turcotte or Child-Pugh classification score as well as to the galactose elimination capacity of these patients. Using reversed-phase high pressure liquid chromatography caffeine, paraxanthine, theophylline, and theobromine were analysed in blood plasma collected before and after an oral dose of caffeine. Compared to apparent caffeine pharmacokinetics in patients with normal livers or miscellaneous liver disease, cirrhosis was characterized by a statistically significant reduction in apparent caffeine clearance and prolongation in half-life. The reduced apparent plasma disappearance rate of caffeine in cirrhotics was related to the retarded formation of paraxanthine which was the main metabolite of caffeine in blood plasma both in the absence or presence of liver disease. The apparent caffeine clearance in cirrhosis decreased with increasing Child-Turcotte classification score: Child's class A patients differed significantly from Child's class B or Child's class C patients, whereas the difference between Child's class B and C patients did not reach statistical significance (Wilcoxon's rank test). In addition there was a strong correlation between the Child-Pugh classification score and apparent caffeine clearance (P less than 0.001). However, no correlation existed between Child's classification and galactose elimination capacity. Our data emphasize the value of the Child-Turcotte or Child-Pugh classification in assessing the severity of liver cirrhosis in a simpler and less time-consuming way than using quantitative liver function tests.

摘要

相似文献

1
Correlation of caffeine elimination and Child's classification in liver cirrhosis.
Klin Wochenschr. 1989 Jan 4;67(1):6-15. doi: 10.1007/BF01736528.
2
Serum metabolite/caffeine ratios as a test for liver function.
J Clin Pharmacol. 2004 Apr;44(4):338-47. doi: 10.1177/0091270004263468.
3
A simple useful method for the determination of hepatic function in patients with liver cirrhosis using caffeine and its three major dimethylmetabolites.一种利用咖啡因及其三种主要二甲基代谢物测定肝硬化患者肝功能的简单实用方法。
Int J Clin Pharmacol Ther Toxicol. 1992 Sep;30(9):336-41.
4
The theophylline disposition after caffeine administration in liver cirrhosis: an index of liver function.肝硬化患者服用咖啡因后茶碱的处置:一项肝功能指标
Ital J Gastroenterol. 1992 Jul-Aug;24(6):332-7.
5
[Diagnostic value of the study of caffeine elimination in chronic liver diseases].
Orv Hetil. 1995 Apr 30;136(18):927-32.
6
[Caffeine blood concentration as an indicator of liver damage in patients with cirrhosis--correlation with Child's classification].
Wiad Lek. 1990;43(9-10):412-6.
7
Accumulation of theophylline, theobromine and paraxanthine in the fetal rat brain following a single oral dose of caffeine.单次口服咖啡因后胎鼠脑中茶碱、可可碱和副黄嘌呤的蓄积
Brain Res Dev Brain Res. 1993 Oct 15;75(2):193-9. doi: 10.1016/0165-3806(93)90023-4.
8
Measurements of caffeine and plasma metabolite/caffeine ratios as a test for hepatic drug-oxidizing capacity in goats.
Xenobiotica. 2011 Jul;41(7):585-92. doi: 10.3109/00498254.2011.572199. Epub 2011 Apr 9.
9
Comparative pharmacokinetics of caffeine and three metabolites in clinically normal horses and donkeys.咖啡因及其三种代谢物在临床正常马匹和驴中的比较药代动力学。
Am J Vet Res. 1997 Aug;58(8):881-4.
10
Population pharmacokinetics of caffeine and its metabolites theobromine, paraxanthine and theophylline after inhalation in combination with diacetylmorphine.吸入二乙酰吗啡后咖啡因及其代谢物可可碱、副黄嘌呤和茶碱的群体药代动力学。
Basic Clin Pharmacol Toxicol. 2005 Jan;96(1):71-9. doi: 10.1111/j.1742-7843.2005.pto960111.x.

引用本文的文献

1
Identification of Gut Microbial Lysine and Histidine Degradation and CYP-Dependent Metabolites as Biomarkers of Fatty Liver Disease.鉴定肠道微生物赖氨酸和组氨酸降解物及 CYP 依赖性代谢产物作为非酒精性脂肪性肝病的生物标志物。
mBio. 2023 Feb 28;14(1):e0266322. doi: 10.1128/mbio.02663-22. Epub 2023 Jan 30.
2
Pharmacokinetics of Caffeine: A Systematic Analysis of Reported Data for Application in Metabolic Phenotyping and Liver Function Testing.咖啡因的药代动力学:对用于代谢表型分析和肝功能测试的报告数据的系统分析
Front Pharmacol. 2022 Feb 25;12:752826. doi: 10.3389/fphar.2021.752826. eCollection 2021.
3
The role of salivary caffeine clearance in the diagnosis of chronic liver disease.

本文引用的文献

1
Impaired elimination of caffeine in cirrhosis.肝硬化患者咖啡因清除受损。
Dig Dis Sci. 1980 Mar;25(3):193-7. doi: 10.1007/BF01308138.
2
Serum caffeine half-lives. Healthy subjects vs. patients having alcoholic hepatic disease.
Am J Clin Pathol. 1980 Mar;73(3):390-3. doi: 10.1093/ajcp/73.3.390.
3
Impaired elimination of caffeine by oral contraceptive steroids.口服避孕药类固醇对咖啡因清除的损害。
J Lab Clin Med. 1980 Apr;95(4):603-8.
唾液咖啡因清除率在慢性肝病诊断中的作用。
J Oral Biol Craniofac Res. 2015 Jan-Apr;5(1):28-33. doi: 10.1016/j.jobcr.2014.12.003. Epub 2015 Jan 23.
4
Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.早产儿呼吸暂停的治疗和预防中使用甲基黄嘌呤治疗。
Paediatr Drugs. 2014 Apr;16(2):169-77. doi: 10.1007/s40272-013-0063-z.
5
Reliability of total overnight salivary caffeine assessment (TOSCA) for liver function evaluation in compensated cirrhotic patients.总夜间唾液咖啡因评估(TOSCA)在代偿期肝硬化患者肝功能评估中的可靠性。
Eur J Clin Pharmacol. 2006 Aug;62(8):605-12. doi: 10.1007/s00228-006-0146-7. Epub 2006 Jul 14.
6
Pharmacokinetics and sedative effects in healthy subjects and subjects with impaired liver function after continuous infusion of clomethiazole.健康受试者和肝功能受损受试者持续输注氯美噻唑后的药代动力学及镇静作用
Eur J Clin Pharmacol. 2003 Jun;59(2):117-22. doi: 10.1007/s00228-003-0598-y. Epub 2003 May 7.
7
Effects of liver disease on pharmacokinetics. An update.肝脏疾病对药代动力学的影响。最新进展。
Clin Pharmacokinet. 1999 Nov;37(5):399-431. doi: 10.2165/00003088-199937050-00004.
8
Clinical pharmacokinetics in patients with liver disease.肝病患者的临床药代动力学
Clin Pharmacokinet. 1991 Jul;21(1):42-69. doi: 10.2165/00003088-199121010-00004.
4
A peek at the Child-Turcotte classification.一瞥儿童-图尔科特分类法。
Hepatology. 1981 Nov-Dec;1(6):673-6. doi: 10.1002/hep.1840010617.
5
Decreased systemic clearance of caffeine due to cimetidine.西咪替丁导致咖啡因的全身清除率降低。
Br J Clin Pharmacol. 1981 Aug;12(2):155-9. doi: 10.1111/j.1365-2125.1981.tb01194.x.
6
Caffeine disposition after oral doses.口服剂量后的咖啡因处置情况。
Clin Pharmacol Ther. 1982 Jul;32(1):98-106. doi: 10.1038/clpt.1982.132.
7
Disposition of caffeine and its metabolites in man.咖啡因及其代谢产物在人体内的处置情况。
J Pharmacol Exp Ther. 1983 Jan;224(1):180-5.
8
The absolute bioavailability of caffeine in man.咖啡因在人体中的绝对生物利用度。
Eur J Clin Pharmacol. 1983;24(1):93-8. doi: 10.1007/BF00613933.
9
The caffeine CO2 breath test: dose response and route of N-demethylation in smokers and nonsmokers.咖啡因二氧化碳呼气试验:吸烟者和非吸烟者的剂量反应及N-去甲基化途径
Clin Pharmacol Ther. 1982 Aug;32(2):261-9. doi: 10.1038/clpt.1982.157.
10
Assessment of the cytochrome P-448 dependent liver enzyme system by a caffeine breath test.通过咖啡因呼气试验评估细胞色素P-448依赖的肝脏酶系统。
Eur J Clin Pharmacol. 1981;21(1):53-9. doi: 10.1007/BF00609588.